文献速递肝胆胰外科

基于阳性淋巴结数目对胰腺癌进行分期

Staging of pancreatic cancer based on the number of positive lymph nodes.
PubMed 文献 · Br J Surg · 2017-02-14

该研究基于SEER数据库2004至2012年5036例I-II期胰腺癌切除患者,评估阳性淋巴结数目对生存的预测价值。结论认为阳性淋巴结数目是胰腺癌的预后因素。

要点

  • 胰腺癌切除标本中阳性淋巴结数目可细化分期,2枚为最佳区分阈值。
  • pN1a(1-2枚阳性)和pN1b(≥3枚阳性)患者死亡风险逐级升高。
  • 阳性淋巴结数目是胰腺癌独立预后因素,应纳入病理分期评估。

核心结论

  • 胰腺癌切除标本中阳性淋巴结数目是预后因素,可细化分期。

研究设计与样本

  • 基于SEER数据库的 population-based 研究,纳入2004至2012年接受胰腺切除术的I-II期胰腺癌患者5036例。
  • 中位随访15个月(i.q.r. 8-28)。
  • 采用广义ROC曲线分析和倾向性评分校正的Cox回归分析评估阳性淋巴结数目的预测价值。

主要发现

  • ROC曲线分析显示2枚阳性淋巴结最佳区分总生存。
  • 倾向性评分校正的Cox回归分析证实上述结果。

临床怎么用

  • 胰腺癌切除术后病理报告应明确阳性淋巴结数目,并按pN0、pN1a(1-2枚)、pN1b(≥3枚)进行细化分期。
  • 阳性淋巴结数目可用于预后分层,指导术后辅助治疗决策和随访强度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The International Study Group on Pancreatic Surgery has stated that at least 12 lymph nodes should be evaluated for staging of pancreatic cancer. The aim of this population-based study was to evaluate whether the number of positive lymph nodes refines staging. METHODS: Patients who underwent pancreatectomy for stage I-II pancreatic cancer between 2004 and 2012 were identified from the Surveillance, Epidemiology, and End Results database. The predictive value of the number of positive lymph nodes for survival was assessed by generalized receiver operating characteristic (ROC) curve analysis and propensity score-adjusted Cox regression analysis. RESULTS: Some 5036 patients were included, with a median of 18 (i.q.r. 15-24) lymph nodes examined. Positive lymph nodes were found in 3555 patients (70·6 per cent). The median duration of follow-up was 15 (i.q.r. 8-28) months. ROC curve analysis revealed that two positive lymph nodes best discriminated overall survival. Patients with one or two positive lymph nodes (pN1a) and those with three or more positive lymph nodes (pN1b) had an increased risk of overall mortality compared with patients who were node-negative (pN0): hazard ratio (HR) 1·47 (95 per cent c.i. 1·33 to 1·64) and HR 2·01 (1·82 to 2·22) respectively. These findings were confirmed by propensity score-adjusted Cox regression analysis. The 5-year overall survival rates were 39·8 (95 per cent c.i. 36·5 to 43·3) per cent for patients with pN0, 21·0 (18·6 to 23·6) per cent for those with pN1a and 11·4 (9·9 to 13·3) per cent for patients with pN1b disease. CONCLUSION: The number of positive lymph nodes in the resection specimen is a prognostic factor in patients with pancreatic cancer.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Tarantino I, Warschkow R, Hackert T, et al. Staging of pancreatic cancer based on the number of positive lymph nodes. Br J Surg. 2017. PMID: 28195303. doi:10.1002/bjs.10472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。